Perfil
Jeroen Rovers formerly worked at Organon NV, as Director-Clinical Development, Kiadis Pharma BV, as Chief Medical Officer from 2014 to 2015, DCPrime BV, as Chief Medical Officer from 2018 to 2020, Ceronco Biosciences, as Chief Medical Officer, and Mendus AB, as Chief Medical Officer from 2021 to 2025.
Dr. Rovers received his doctorate degree from the University of Leiden.
Antiguos cargos conocidos de Jeroen Rovers.
| Empresas | Cargo | Fin |
|---|---|---|
| MENDUS AB | Director Técnico/Científico/I+D | 05/05/2025 |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Director Técnico/Científico/I+D | 01/12/2020 |
Ceronco Biosciences | Director Técnico/Científico/I+D | - |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Corporate Officer/Principal | - |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Director Técnico/Científico/I+D | - |
Formación de Jeroen Rovers.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Health Technology |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Ceronco Biosciences |
- Bolsa de valores
- Insiders
- Jeroen Rovers
















